Advertisement
Marie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, Jeremy Price, Hitoshi Takizawa, Hélène Salmon, Juliana Idoyaga, Albert Ruzo, Philip J. Lupo, M. John Hicks, Albert Shih, Stephen J. Simko, Harshal Abhyankar, Rikhia Chakraborty, Marylene Leboeuf, Monique Beltrão, Sérgio A. Lira, Kenneth M. Heym, Björn E. Clausen, Venetia Bigley, Matthew Collin, Markus G. Manz, Kenneth McClain, Miriam Merad, Carl E. Allen; BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med 9 February 2015; 212 (2): 281. doi: https://doi.org/10.1084/jem.2013097701202015c
Download citation file:
Vol. 211, No. 4, April 7, 2014. Pages 669–683.
The authors regret that Björn E. Clausen did not appear in the original author list. His affiliation is Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany. The HTML and PDF versions of this article have been corrected.
Advertisement
